Epigallocatechin-3-gallate Attenuates Lipopolysaccharide-Induced Inflammation in Human Retinal Endothelial Cells

Hui-Yan Zhang,Jian-Yong Wang,Hang-Ping Yao
DOI: https://doi.org/10.3980/j.issn.2222-3959.2014.03.04
2014-01-01
Abstract:AIM: To investigate the mechanism underlying the anti -inflammatory effects of epigallocatechin -3 -gallate (EGCG) in lipopolysaccharide (LPS) -stimulated human retinal endothelial cells (HRECs).METHODS: HRECs pre-treated with EGCG (0-100 pmol/L) were stimulated with LPS (250 ng/mL). Levels of tumor necrosis factor alpha (TNF -alpha), vascular endothelial growth factor (VEGF), monocyte chemotactic protein -1 (MCP-1) and nitric oxide (NO) in the supernatants were determined by enzyme -linked immunosorbent assay (ELISA) and Griess assay. The protein expression of phosphorylated extracellular signal -regulated kinase (ERK) 1/2 and p38 mitogen -activated protein kinases (p38) were determined by Western blot analysis.RESULTS: EGCG pre-treatment significantly inhibited the secretion of TNF -a, VEGF, MCP-1 and NO in LPS stimulated HRECs. Moreover, EGCG effectively attenuated LPS -induced activation and phosphorylation of ERK1/2 and p38 in HRECs in a dose -dependent manner.CONCLUSION: EGCG exhibited inhibitory effects on LPS-induced pro-inflammatory cytokines production by modulating ERK1/2 and p38 pathways in HRECs, suggesting EGCG as a potential candidate for anti inflammatory intervention.
What problem does this paper attempt to address?